- Aged 18 years or older and able to understand and sign the informed consent form.
- Patients diagnosed with hyperlipidemia and a very high risk developing
cardiovascular disease prescribed statin treatment according to clinical praxis
and the recommendations set forth in the MPA national guideline for treatment of
- Patients contraindicated for statin treatment according to market authorization for
these drugs should be excluded from the study.
- Patients participating in other clinical trials or non-interventional studies.